Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in Kaposi's sarcoma

P L Myskowski1, R Ahkami

  • 1Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Dermatologic Clinics
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outpatient dermatology consultations for oncology patients with acute dermatologic adverse events impact anticancer therapy interruption: a retrospective study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Understanding racial disparities in mycosis fungoides through international collaborative studies.

The British journal of dermatology·2019
Same author

Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same author

Acneiform follicular mucinosis: an indolent follicular mucinosis variant unrelated to mycosis fungoides?

Clinical and experimental dermatology·2018
Same author

The optimal regimen of brentuximab vedotin for CD30<sup>+</sup> cutaneous lymphoma: are we there yet?

The British journal of dermatology·2017
Same author

Dermoscopy and the diagnosis of primary cutaneous B-cell lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Kaposi sarcoma (KS) is an opportunistic neoplasm presenting diagnostic challenges. Its pathogenesis involves genetic predisposition, viral infection, and cytokine-driven tumor growth, with KSHV

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Kaposi sarcoma (KS) remains a clinical challenge over 100 years after its initial description.
  • Ongoing debate exists regarding the cell of origin and its classification as a true cancer.
  • KS exhibits a dual nature, starting as a benign hyperproliferative process and progressing to an aggressive malignancy.

Purpose of the Study:

  • To summarize the current understanding of Kaposi sarcoma (KS) pathogenesis.
  • To highlight the complexities in diagnosing and classifying KS.
  • To underscore the role of predisposing factors, infectious agents, and cytokines in KS development.

Main Methods:

  • Literature review and synthesis of existing research on KS.
  • Analysis of clinical observations and etiological hypotheses.

Related Experiment Videos

  • Discussion of the proposed role of viral agents, particularly KSHV, and cytokines.

    • Main Results:

    • KS pathogenesis likely involves a combination of genetic susceptibility, immune compromise, and exposure to an infectious agent, most commonly a virus.
    • Cytokines play a significant role in promoting tumor growth.
    • The precise role of KSHV in KS development requires further extensive investigation.

    Conclusions:

    • KS is an opportunistic neoplasm with a complex etiology.
    • Understanding the interplay between host factors, viral agents (like KSHV), and cytokines is crucial for future research and therapeutic strategies.
    • Further investigation into KSHV's role is warranted to fully elucidate KS pathogenesis.